• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺滤泡细胞肿瘤的发病机制

Pathogenetic mechanisms in thyroid follicular-cell neoplasia.

作者信息

Kondo Tetsuo, Ezzat Shereen, Asa Sylvia L

机构信息

Department of Pathology, University Health Network and Toronto Medical Laboratories, Department of Laboratory Medicine and Pathology, University of Toronto, 200 Elizabeth Street, Toronto, Ontario, Canada M5G 2C4.

出版信息

Nat Rev Cancer. 2006 Apr;6(4):292-306. doi: 10.1038/nrc1836.

DOI:10.1038/nrc1836
PMID:16557281
Abstract

Thyroid cancer is one of the few malignancies that are increasing in incidence. Recent advances have improved our understanding of its pathogenesis; these include the identification of genetic alterations that activate a common effector pathway involving the RET-Ras-BRAF signalling cascade, and other unique chromosomal rearrangements. Some of these have been associated with radiation exposure as a pathogenetic mechanism. Defects in transcriptional and post-transcriptional regulation of adhesion molecules and cell-cycle control elements seem to affect tumour progression. This information can provide powerful ancillary diagnostic tools and can also be used to identify new therapeutic targets.

摘要

甲状腺癌是少数发病率正在上升的恶性肿瘤之一。最近的进展增进了我们对其发病机制的理解;这些进展包括识别出激活涉及RET-Ras-BRAF信号级联的共同效应通路的基因改变,以及其他独特的染色体重排。其中一些与辐射暴露作为发病机制有关。黏附分子和细胞周期控制元件的转录和转录后调控缺陷似乎会影响肿瘤进展。这些信息可提供强大的辅助诊断工具,也可用于识别新的治疗靶点。

相似文献

1
Pathogenetic mechanisms in thyroid follicular-cell neoplasia.甲状腺滤泡细胞肿瘤的发病机制
Nat Rev Cancer. 2006 Apr;6(4):292-306. doi: 10.1038/nrc1836.
2
Chromosomal aberrations in thyroid follicular-cell neoplasia: in the search of novel oncogenes and tumour suppressor genes.甲状腺滤泡细胞肿瘤中的染色体异常:寻找新的癌基因和肿瘤抑制基因。
Mol Cell Endocrinol. 2010 May 28;321(1):57-66. doi: 10.1016/j.mce.2009.11.014. Epub 2009 Dec 2.
3
Cytogenetic and molecular events in adenoma and well-differentiated thyroid follicular-cell neoplasia.腺瘤和高分化甲状腺滤泡细胞肿瘤中的细胞遗传学和分子事件。
Cancer Genet Cytogenet. 2010 Nov;203(1):21-9. doi: 10.1016/j.cancergencyto.2010.08.025.
4
Molecular genetic study comparing follicular variant versus classic papillary thyroid carcinomas: association of N-ras mutation in codon 61 with follicular variant.比较滤泡型与经典型乳头状甲状腺癌的分子遗传学研究:第61密码子N-ras突变与滤泡型的关联
Hum Pathol. 2006 Jul;37(7):824-30. doi: 10.1016/j.humpath.2006.01.030. Epub 2006 May 19.
5
Follicular thyroid carcinoma: chromosome analysis of 19 cases.滤泡性甲状腺癌:19例病例的染色体分析
Genes Chromosomes Cancer. 1998 Mar;21(3):250-5.
6
Translocation (10;14)(q24;q32) as the sole chromosomal abnormality in a metastatic follicular thyroid carcinoma.易位(10;14)(q24;q32)作为转移性滤泡状甲状腺癌唯一的染色体异常。
Cancer Genet Cytogenet. 2009 Apr 1;190(1):43-5. doi: 10.1016/j.cancergencyto.2008.11.009.
7
Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.在TRbetaPV/PV小鼠中自发产生的甲状腺肿瘤来源的细胞系中的染色体畸变。
Cancer Genet Cytogenet. 2005 Sep;161(2):104-9. doi: 10.1016/j.cancergencyto.2005.02.007.
8
Genetic mutations in thyroid carcinoma.甲状腺癌中的基因突变
Minerva Endocrinol. 2009 Mar;34(1):11-28.
9
Management of follicular tumors of the thyroid.
Minerva Chir. 2007 Oct;62(5):373-82.
10
Frizzled-1 is down-regulated in follicular thyroid tumours and modulates growth and invasiveness.卷曲蛋白-1在甲状腺滤泡性肿瘤中表达下调,并调节肿瘤生长和侵袭能力。
J Pathol. 2008 May;215(1):87-96. doi: 10.1002/path.2331.

引用本文的文献

1
A bibliometric analysis of inflammation and thyroid carcinoma: research trends and future perspectives.炎症与甲状腺癌的文献计量分析:研究趋势与未来展望
Front Oncol. 2025 Aug 1;15:1593006. doi: 10.3389/fonc.2025.1593006. eCollection 2025.
2
Viral infection and thyroid disorders: a narrative review.病毒感染与甲状腺疾病:一篇综述
Front Microbiol. 2025 Jun 13;16:1625179. doi: 10.3389/fmicb.2025.1625179. eCollection 2025.
3
All-cause mortality in patients with medullary thyroid carcinoma of different ages: an inverse L-curve analysis study.
不同年龄甲状腺髓样癌患者的全因死亡率:一项倒L曲线分析研究
Front Endocrinol (Lausanne). 2025 Jun 10;16:1574985. doi: 10.3389/fendo.2025.1574985. eCollection 2025.
4
NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Development of 3D organoid models to study aggressive thyroid cancers.晚期甲状腺癌的新见解:从机制到治疗:用于研究侵袭性甲状腺癌的3D类器官模型的开发
Eur Thyroid J. 2025 Jul 2;14(4). doi: 10.1530/ETJ-24-0392. Print 2025 Aug 1.
5
Thyroid Cancer: Epidemiology, Classification, Risk Factors, Diagnostic and Prognostic Markers, and Current Treatment Strategies.甲状腺癌:流行病学、分类、危险因素、诊断和预后标志物以及当前的治疗策略。
Int J Mol Sci. 2025 May 28;26(11):5173. doi: 10.3390/ijms26115173.
6
Real-world treatment outcomes and clinicopathologic and molecular determinants of response to first-line lenvatinib in patients with advanced follicular cell-derived thyroid cancer.晚期滤泡细胞源性甲状腺癌患者一线乐伐替尼治疗的真实世界治疗结果及反应的临床病理和分子决定因素
BJC Rep. 2025 Jun 3;3(1):41. doi: 10.1038/s44276-025-00153-2.
7
Paediatric Thyroid Carcinoma: The Genetic Revolution and Its Implications for Therapy and Outcomes.小儿甲状腺癌:基因革命及其对治疗和预后的影响
Cancers (Basel). 2025 May 2;17(9):1549. doi: 10.3390/cancers17091549.
8
Clinical characteristics and prognosis of histological subtypes of papillary thyroid carcinoma in pediatric patients.儿童甲状腺乳头状癌组织学亚型的临床特征及预后
Endocr Oncol. 2025 Apr 14;5(1):e240078. doi: 10.1530/EO-24-0078. eCollection 2025 Jan.
9
Emerging Potential of Metabolomics in Thyroid Cancer-A Comprehensive Review.代谢组学在甲状腺癌中的新兴潜力——综述
Cancers (Basel). 2025 Mar 18;17(6):1017. doi: 10.3390/cancers17061017.
10
The 2024 revised clinical guidelines on the management of thyroid tumors by the Japan Association of Endocrine Surgery.日本内分泌外科学会2024年修订的甲状腺肿瘤管理临床指南。
Endocr J. 2025 May 7;72(5):545-635. doi: 10.1507/endocrj.EJ24-0644. Epub 2025 Mar 8.